Alector

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alector and other ETFs, options, and stocks.

About ALEC

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. 

CEO
Arnon Rosenthal
CEOArnon Rosenthal
Employees
103
Employees103
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2013
Founded2013
Employees
103
Employees103

ALEC Key Statistics

Market cap
262.11M
Market cap262.11M
Price-Earnings ratio
-1.71
Price-Earnings ratio-1.71
Dividend yield
Dividend yield
Average volume
1.16M
Average volume1.16M
High today
$2.65
High today$2.65
Low today
$2.30
Low today$2.30
Open price
$2.40
Open price$2.40
Volume
1.82M
Volume1.82M
52 Week high
$3.40
52 Week high$3.40
52 Week low
$0.87
52 Week low$0.87

Stock Snapshot

The current Alector(ALEC) stock price is $2.40, with a market capitalization of 262.11M. The stock trades at a price-to-earnings (P/E) ratio of -1.71.

As of 2026-03-11, Alector(ALEC) stock has fluctuated between $2.30 and $2.65. The current price stands at $2.40, placing the stock +4.3% above today's low and -9.5% off the high.

Alector(ALEC) shares are trading with a volume of 1.82M, against a daily average of 1.16M.

During the past year, Alector(ALEC) stock moved between $0.87 at its lowest and $3.40 at its peak.

During the past year, Alector(ALEC) stock moved between $0.87 at its lowest and $3.40 at its peak.

ALEC News

Seeking Alpha 13h
Alector rises as BTIG upgrades to Buy on strategic shift

Alector (ALEC) shares climbed ~15% on Tuesday after BRIG upgraded the neurology-focused biotech to Buy from Neutral, citing its recent strategic shift to treatm...

Alector rises as BTIG upgrades to Buy on strategic shift
TipRanks 22h
BTIG upgrades Alector to Buy on shift to novel therapeutics

BTIG analyst Thomas Shrader upgraded Alector (ALEC) to Buy from Neutral with a $6 price target The upgrade reflects the company’s shift in focus to the developm...

Analyst ratings

50%

of 8 ratings
Buy
25%
Hold
50%
Sell
25%

People also own

Based on the portfolios of people who own ALEC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.